The combination of adenosine-triphosphatase inhibition and provision of high-energy phosphates for the preservation of unperfused myocardium, assessed by ventricular function, histochemistry and birefringence.
D000249:Adenosine Monophosphate / Q000494:pharmacology; D000251:Adenosine Triphosphatases / Q000037:antagonists & inhibitors*; D000255:Adenosine Triphosphate / Q000494:pharmacology; D000818:Animals; D001696:Biomechanical Phenomena; D001718:Birefringence; D001794:Blood Pressure; D004285:Dogs; D006334:Heart Function Tests; D016027:Heart Transplantation; D006651:Histocytochemistry; D007036:Hypothermia, Induced; D008996:Monoamine Oxidase Inhibitors / Q000494:pharmacology*; D009206:Myocardium / Q000378:metabolism*; D009840:Oligomycins / Q000494:pharmacology*; D010101:Oxygen Consumption; D010477:Perfusion; D010710:Phosphates / Q000494:pharmacology*; D010725:Phosphocreatine / Q000494:pharmacology; D014021:Tissue Preservation
D008996:Monoamine Oxidase Inhibitors; D009840:Oligomycins; D010710:Phosphates; D010725:Phosphocreatine; D000249:Adenosine Monophosphate; D000255:Adenosine Triphosphate; D000251:Adenosine Triphosphatases